Levels of mutagens in the urine of smokers of black and blond tobacco correlate with their risk of bladder cancer.
Levels of urinary mutagens, thioethers, N-nitrosamino acids, nitrate, nicotine, cotinine and creatinine were measured in 21 non-smokers, 26 smokers of blond tobacco, 9 smokers of black tobacco and 5 smokers of both types of tobacco, all eating a similar diet. Results were expressed either per 24 h urine or per mmol creatinine. The sum of urinary nicotine and cotinine levels (N + C) was used as a measure of exposure to the number of cigarettes smoked. Statistically significant positive dose-effect relationships were obtained between the urinary N + C levels and (i) the number of revertants (Salmonella typhimurium TA98, with a metabolic activation system); (ii) the concentration of thioethers; (iii) the levels of N-nitrosoproline or the sum of all nitrosamino acids excreted and (iv) the amount of urinary nitrate. No such correlation was found between N + C levels and induction potency in the SOS chromotest. A linear dose-effect relationship between urinary mutagenicity (i.e. log revertants of S. typhimurium TA98) and N + C levels or number of cigarettes per day was established for smokers of blond tobacco. After adjustment for N + C levels, the urine of smokers of black tobacco contained twice as much mutagenic material as did the urine of blond tobacco smokers (P = 0.02). For other exposure markers, no statistically significant difference was found between the two types of smokers. Epidemiological studies have shown that the risk of urinary bladder cancer is 2.5 times higher in smokers of black tobacco than in blond tobacco. Therefore, our findings on urinary mutagenicity provide experimental evidence that the type of tobacco is the factor responsible for the observed difference in risk and that smoking of black as compared to blond tobacco results in a higher exposure of the urinary bladder to genotoxic hence potentially carcinogenic substances.
Malaveille
C
C
Unit of Environmental Carcinogens and Host Factors, IARC, Lyon, France.
Vineis
P
P
Estéve
J
J
Ohshima
H
H
Brun
G
G
Hautefeuille
A
A
Gallet
P
P
Ronco
G
G
Terracini
B
B
Bartsch
H
H
D003367:Cotinine / Q000652:urine; D003404:Creatinine / Q000652:urine; D004260:DNA Repair; D006801:Humans; D008297:Male; D009153:Mutagens / Q000032:analysis*; D009538:Nicotine / Q000652:urine; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects* / Q000378:metabolism; D001749:Urinary Bladder Neoplasms / Q000209:etiology*; D014556:Urine / Q000032:analysis*
D009153:Mutagens; D009538:Nicotine; D003404:Creatinine; D003367:Cotinine